Skip to Content

User Reviews for Clear Eyes Contact Lens Multi-Action Relief

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Reviews for Clear Eyes Contact Lens Multi-Action Relief

For Eye Redness "My skin became bright red when this leaked from my eyes."

2.0

Buttercup9 (taken for 1 to 2 years) July 9, 2016

0 users found this comment helpful.
Did you? Yes No | Report inappropriate

More about Clear Eyes Contact Lens Multi-Action Relief (ocular lubricant ophthalmic)

Consumer resources

Clear Eyes CLR

Other brands: Systane, Artificial Tears, Refresh, Systane Ultra, ... +44 more

Professional resources

Related treatment guides

Dry Eye Disease

Drug Status

Rx
OTC

Availability Rx and/or OTC

Pregnancy Category Not classified

CSA Schedule* Not a controlled drug

Dry Eye

Drug Class

Ophthalmic lubricants and irrigations

Related Drugs

Dry Eye Disease Restasis, Xiidra, cyclosporine ophthalmic, Systane, Artificial Tears, Refresh, Systane Ultra, Refresh Tears, lifitegrast ophthalmic, TheraTears, Gonak Hypromellose, GenTeal, Lacri-Lube S.O.P., Lacrisert, Refresh Optive, Liquitears, Tears Naturale II, Refresh Liquigel, optive, Goniosol, Oasis Tears, More...

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions & Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Help and Support

Looking for answers? Ask a question

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated June 1st, 2018), Cerner Multum™ (updated July 4th, 2018), Wolters Kluwer™ (updated June 4th, 2018) and others. To view content sources and attributions, please refer to our editorial policy.